CN Patent
CN116712415A — 一种多奈哌齐口溶膜及其制备方法
Assigned to Lipin Pharmaceutical Xiamen Co ltd · Expires 2023-09-08 · 3y expired
What this patent protects
本发明公开了一种多奈哌齐口溶膜及其制备方法,该口溶膜为双层膜结构,包括含有45‑75%w/w盐酸多奈哌齐的载药层和不含盐酸多奈哌齐的背衬层。本口溶膜中盐酸多奈哌齐处于结晶状态,以降低杂质增长,处方中还含有优选的疏水材料,以提高药物稳定性并降低药物在口腔中的溶出量。
USPTO Abstract
本发明公开了一种多奈哌齐口溶膜及其制备方法,该口溶膜为双层膜结构,包括含有45‑75%w/w盐酸多奈哌齐的载药层和不含盐酸多奈哌齐的背衬层。本口溶膜中盐酸多奈哌齐处于结晶状态,以降低杂质增长,处方中还含有优选的疏水材料,以提高药物稳定性并降低药物在口腔中的溶出量。
Drugs covered by this patent
- Subutex (Buprenorphine Hydrochloride) · Indivior
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.